The PIT: SToPP Trial—A Feasibility Randomised Controlled Trial of Home-Based Physiotherapy for People with Parkinson's Disease Using Video-Based Measures to Preserve Assessor Blinding

Table 2

Changes in outcomes (weeks 0–12, by group) in participants who completed a measure on at least three occasions; values presented are medians (interquartile range).

Primary outcomes	Group	Week 0	Week 4	Week 8	Week 12
PAS chair transfer (score)	Control (𝑛=18)	6 (4–7)	4 (4–6)	6 (4–7)	6 (3–7)
	Physiotherapy (𝑛=19)	4 (4–6)	6 (4–7)	7 (5–8)	7 (4–8)
Sit-to-stand time (s)	Control (𝑛=20)	2.2 (1.4–3.2)	1.9 (1.3–2.8)	2.0 (1.4–2.2)	1.7 (1.3–2.2)
	Physiotherapy (𝑛=18)	2.2 (1.6–3.1)	1.9 (1.4–2.0)	1.7 (1.0–2.4)	1.5 (1.2–2.0)
SAS (score)	Control (𝑛=18)	52 (40–64)	59 (45–71)	60 (48–66)	64 (50–77)
	Physiotherapy (𝑛=16)	50 (43–59)	49 (43–67)	58 (50–66)	52 (43–60)
Secondary outcomes
SS-180 turn time (s)	Control (𝑛=16)	3.7 (3.1–6.8)	3.9 (3.1–7.0)	4.1 (2.7–9.6)	3.9 (2.8–5.9)
	Physiotherapy (𝑛=16)	5.3 (3.9–6.7)	4.4 (3.4–6.4)	3.7 (3.4–4.8)	3.8 (3.1–6.1)
FR (cm)	Control (𝑛=16)	20.9 (15.7–25.2)	21.0 (15.0–24.3)	21.7 (13.6–25.8)	19.7 (17.4–27.7)
	Physiotherapy (𝑛=13)	19.2 (17.5–21.9)	22.0 (20.0–25.0)	22.8 (20.3–25.8)	25.5 (19.6–30.2)
UPDRS posture (score)	Control (𝑛=19)	1 (1-2)	1 (1-2)	1 (1-2)	1 (1-2)
	Physiotherapy (𝑛=19)	1 (1-2)	1 (1-2)	1 (1-2)	1 (1-2)
HR-QOL score	Control (𝑛=14)	29 (26–31)	30 (25–33)	29 (25–33)	31 (24–34)
	Physiotherapy (𝑛=14)	29 (26–36)	30 (28–36)	32 (28–38)	29 (27–34)